P17987 (TCPA_HUMAN) Homo sapiens (Human)

T-complex protein 1 subunit alpha UniProtKBInterProSTRINGInteractive Modelling

556 aa; Sequence (Fasta) ; 3 identical sequences: Pan troglodytes: A0A6D2VYN1, G2HIL6; Gorilla gorilla gorilla: G3RDV8

Available Structures

49 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human TRiC-tubulin-S3
7x0s
 Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		3-539
16×ADP; 16×MG; 16×AF3;
Assess
cryo-EM structure of human TRiC-ADP-AlFx
7x0v
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		3-539
16×ADP; 16×MG; 16×AF3;
Assess
cryo-EM structure of human TRiC-ATP-closed state
7x6q
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		3-539
Assess
CCT G beta 5 complex closed state 14
8sht
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 3
8sg9
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex best PhLP1 class
8sh9
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 4
8sha
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 6
8shn
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 13
8shp
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 12
8shq
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 15
8sgl
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 5
8shl
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex close state 11
8sho
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 2
8sgc
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 10
8shd
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
Human TRiC complex in closed state with nanobody and tubulin bound
7nvn
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q13885; Q99832; 		1-536
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 8
8she
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
Human TRiC complex in closed state with nanobody Nb18, actin and PhLP2A bound
7nvm
 Heteromer
P40227; P48643; P49368; P50990; P50991; P63261; P78371; Q99832; Q9H2J4; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 0
8sff
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 7
8shf
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 1
8sg8
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 9
8shg
 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832; 		2-537
16×ADP; 16×MG; 16×AF3;
Assess
The beta-tubulin folding intermediate IV
7tub
 Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		2-536
8×MG; 8×ADP; 8×AF3;
Assess
The beta-tubulin folding intermediate III
7ttt
 Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		2-536
8×MG; 8×ADP; 8×AF3;
Assess
The beta-tubulin folding intermediate II
7ttn
 Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		2-536
8×AF3; 8×MG; 8×ADP;
Assess
The beta-tubulin folding intermediate I
7trg
 Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		2-536
8×MG; 8×ADP; 8×AF3;
Assess
hTRiC-hPFD Class1 (No PFD)
6nra
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		1-534
Assess
hTRiC-hPFD Class3
6nrc
 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; 		1-534
Assess
hTRiC-hPFD Class4
6nrd
 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; 		1-534
Assess
hTRiC-hPFD Class5
6nr9
 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; 		1-534
Assess
Human TRiC complex in closed state with nanobody bound (Consensus Map)
7nvl
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		3-536
16×ADP; 16×MG; 16×AF3;
Assess
hTRiC-hPFD Class2
6nrb
 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; 		1-534
Assess
hTRiC-hPFD Class6
6nr8
 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; 		1-534
Assess
Human TRiC-PhLP2A-actin complex in the closed state
8ib8
 Heteromer
P40227; P48643; P49368; P50990; P50991; P60709; P78371; Q99832; Q9H2J4; 		3-536
Assess
Human TRiC/CCT complex with reovirus outer capsid protein sigma-3
7lup
 Heteromer
P03527; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		5-536
1×ZN;
Assess
Human TRiC in ATP/AlFx closed state
7lum
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		5-536
Assess
Human TRiC-PhLP2A complex in the closed state
8i1u
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4; 		4-535
16×ADP; 16×MG; 16×AF3;
Assess
Cryo-EM structure of human TRiC-tubulin-S2
7x3j
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		5-533
16×ATP;
Assess
Cryo-EM structure of human TRiC-NPP state
7x0a
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		5-533
Assess
cryo-EM structure of human TRiC-ADP
7x3u
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		5-533
16×ADP;
Assess
Cryo-EM structure of Human TRiC-ATP-open state
7x7y
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		5-533
Assess
Human TRiC open state
8hki
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		5-533
6×ADP;
Assess
Human TRiC-PhLP2A complex in the open state
8i9u
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4; 		13-533
10×ADP;
Assess
CCT G beta 5 complex intermediate state
8sgq
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		13-532
16×ADP;
Assess
Human CCT:mLST8 complex
6qb8
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		13-532
2×ADP;
Assess
Cryo-EM structure of human TRiC-tubulin-S1 state
7wz3
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		14-533
6×ADP;
Assess
Open state CCT-G beta 5 complex
8sfe
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		13-532
16×ADP;
Assess
Human TRiC complex in open state with nanobody bound
7nvo
 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; 		15-533
16×MG; 16×ADP; 12×AF3;
Assess
Prefoldin-tubulin-TRiC complex
7wu7
 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; 		16-531
4×ADP;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7nvl.1.Jmonomer0.763-536
1×ADP; 1×AF3;100.00
Assess